197 related articles for article (PubMed ID: 9287290)
1. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs.
Hajjar DP; Haberland ME
J Biol Chem; 1997 Sep; 272(37):22975-8. PubMed ID: 9287290
[TBL] [Abstract][Full Text] [Related]
2. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Aviram M
Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
[TBL] [Abstract][Full Text] [Related]
3. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture.
Navab M; Berliner JA; Watson AD; Hama SY; Territo MC; Lusis AJ; Shih DM; Van Lenten BJ; Frank JS; Demer LL; Edwards PA; Fogelman AM
Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):831-42. PubMed ID: 8673557
[TBL] [Abstract][Full Text] [Related]
4. The role of oxidized lipoproteins in atherogenesis.
Berliner JA; Heinecke JW
Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
[TBL] [Abstract][Full Text] [Related]
5. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.
Aviram M; Fuhrman B
Mol Cell Biochem; 1998 Nov; 188(1-2):149-59. PubMed ID: 9823020
[TBL] [Abstract][Full Text] [Related]
6. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of atherosclerosis: an overview.
Schwartz CJ; Valente AJ; Sprague EA; Kelley JL; Nerem RM
Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I1-16. PubMed ID: 2044253
[TBL] [Abstract][Full Text] [Related]
8. Lipoproteins and the pathogenesis of atherosclerosis.
Steinberg D
Circulation; 1987 Sep; 76(3):508-14. PubMed ID: 3621517
[TBL] [Abstract][Full Text] [Related]
9. Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor.
Gu X; Kozarsky K; Krieger M
J Biol Chem; 2000 Sep; 275(39):29993-30001. PubMed ID: 11001950
[TBL] [Abstract][Full Text] [Related]
10. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
11. Hydrolysis of lipoproteins by sPLA2's enhances mitogenesis and eicosanoid release from vascular smooth muscle cells: Diverse activity of sPLA2's IIA, V and X.
Pruzanski W; Kopilov J; Kuksis A
Prostaglandins Other Lipid Mediat; 2016 Jan; 122():64-8. PubMed ID: 26711221
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein and scavenger receptor activities are modulated by secretory products derived from cells of the arterial wall.
Aviram M
Metabolism; 1989 May; 38(5):445-9. PubMed ID: 2725283
[TBL] [Abstract][Full Text] [Related]
13. [Cholesterol metabolism in the arteriosclerotic intima].
Künnert B
Zentralbl Allg Pathol; 1989; 135(6):505-9. PubMed ID: 2683497
[TBL] [Abstract][Full Text] [Related]
14. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid (Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation.
Schulz B; Liebisch G; Grandl M; Werner T; Barlage S; Schmitz G
Biochim Biophys Acta; 2007 Oct; 1771(10):1335-44. PubMed ID: 17881287
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein cholesterol and atherosclerosis.
Kruth HS
Curr Mol Med; 2001 Dec; 1(6):633-53. PubMed ID: 11899253
[TBL] [Abstract][Full Text] [Related]
17. [Cellular and molecular bases of cholesterol accumulation in the vascular wall and its contribution to the progression of atherosclerotic lesion].
Llorente V; Badimon L
Rev Esp Cardiol; 1998 Aug; 51(8):633-41. PubMed ID: 9780777
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
Kaplan M; Aviram M
Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.
Ng CJ; Wadleigh DJ; Gangopadhyay A; Hama S; Grijalva VR; Navab M; Fogelman AM; Reddy ST
J Biol Chem; 2001 Nov; 276(48):44444-9. PubMed ID: 11579088
[TBL] [Abstract][Full Text] [Related]
20. [Metabolism of atherogenic lipoproteins].
Beucler I; Turpin G
Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
